Home | Medical-Newswire.Com:
(Medical-NewsWire.com, September 20, 2012 ) New York, NY -- Advanced Medical Isotope Corporation (ADMD) is already a US-based manufacturer and distributor of medical isotopes and is also developing key technologies that may offer a superior alternative to the current standard of care for battling cancer with nuclear medicine.
In a Thursday report, VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, identifies key point for optimism regarding the company and examines its speculative potential as an investment. Full report available at: http://vfcsstockhouse.com/blog/article/-advanced-medical-isotope-corporation-expanded-distribution-and-radiogel-technology-hold-the-keys-to-the-future
Advanced Medical Isotope Corporation (ADMD) has - through key partnerships, expanding distribution channels and the acquisition of a license to a novel cancer-fighting technology - well positioned itself to become a growth player in the field of nuclear medicine, specifically in the field of the production and distribution of medical isotopes. Medical isotopes are used in molecular imaging, therapy, and nuclear medicine to diagnose, manage and treat diseases and are deemed a hot item whenever discussed because of the geopolitical implications of non-nuclear nations attempt to enrich uranium for - ahem - solely medical purposes.
Advanced Medical is one of only a few companies in the United States manufacturing and distributing such isotopes and it's likely that business could quickly hit a growth spurt - not only through the company's own indigenous expansion and distribution efforts, but also because of the growing desire of the medical community in the US to use 'home grown' nuclear materials, not to mention increasing regulation that may force the community to do so anyway.
AMIC already offers a broad variety of isotopes and, as outlined in a recent quarterly report, is looking to expand its 'pipeline' of product offerings for its distribution network of customers that include - but is not limited to - national laboratories, hospitals, research facilities and universities.
Many of the company's isotopes are put to use through molecular imaging, or Positron Emission Tomography (PET), which enables Doctors and medical professionals to identify cancerous condictions well before detection means that search for tumor mass. Some of the radiopharmaceutical products based on the medical isotopes are also used in the early detection of certain cardiovascular indications and, as mentioned above, the demand for such products is growing, not shrinking. According to numbers identified in a recent company presentation and credited to the World Nuclear Association, the use of medical isotopes is growing at an annual rate of 10%.
That places AMIC right in the middle of a potential growth boom.
While production and distribution may encompass the company's core business model, AMIC is moving heavily into the field of treatment, too. The process of placing radioactive "seeds" in or near a cancerous tumor is known as brachytherapy, and AMIC is developing a pipeline based on such technology to augment the already-growing core business plan.
In April, the company acquired a license and numerous relating patents to an injectible radiogel technology that could have a significant impact on the next generation of fighting cancer. Using the radiogel technology doctors could deliver Yttrium-90 "microspheres" directly into cancerous tissue. Because the injectible polymer turns solid and holds the microspheres in place, there is little to no threat of any radiation escaping and damaging surrounding tissue. As described by Dr. Alan Walter, Chair of the AMIC Scientific Committee, in a presentation available on the company's home page, such a technology could be termed as using "smart bullets" to target cancerous cells.
Yttrium-90, in the form of Polymer seeds, is an already-established medical isotope with numerous applications in existing cancer treatment and has demonstrated effectiveness in combating head, neck, liver and prostate cancers, according to an above-linked company presentation. The radiogel application of Yttrium-90 could potentially 'storm the scene' in treating numerous cancer types with the intent of targeting those tumors in the hard-to-get to areas of the body that eliminates surgery as an option.
Both the Polymer seeds and the acquired the radiogel technology significantly boost the diversity of AMIC, offering a targeted path to enter the realm of caner treatment to augment the production, sales and distribution channels of its isotopes.
It's possible, based on previous expectations, that the Brachytherapy pipeline could hit market within a couple of years. At that point AMIC could either move forward with commercialization on its own or out-license the technology to someone else and use that revenue stream of royalties to fund the expansion of the core business.
Shares were up by eight percent on Wednesday, although volume was very light. That said, volume has been picking up significantly over the past few months and has tripled already once this year. Volume has also stormed in after the company's more relevant press releases, indicating that there are investors on the sidelines who either wait to play a quick trade or may be taking a 'wait and see' approach to playing this still-speculative stock.
Should the potential of the AMIC distribution network continue to expand and meet the growing demand for nuclear medicine - and should the polymer seeds and radiogel technology also hit market with momentum - then it's likely that the current ADMD share price could start to move. Currently, shares consistently trade for a few pennies above the twenty cents mark, give or take.
Based on the potential of the developing technology, already-available products and future product offerings, the current ADMD trading levels could serve as an opportune accumulation period to those looking at the risk/reward profile for the future. The current market cap of still under twenty million indicates that many investors are still unconvinced, but when searching for potential payoff picks on the bulletin board stocks, it pays off to be in while the stock is still moving along relatively unnoticed, as the best percentage gains to be had in any run start with being in place before the run starts.
That said, the stock market is risky business and there are no sure things, that's why it's up to each investor to conduct his or her own DD and invest accordingly.
Still a developing story worth monitoring.
Disclosure: No position.
Follow ADMD developments and other small cap stocks at VFCsStockHouse.com
Contact VFC's Stock House: email@example.com
Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse
'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks, biopharma stocks, and pharmaceutical and healthcare stocks. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights and opinions into broader-market news. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and make informed and well thought-out investment decisions. For full disclaimer visit: http://vfcsstockhouse.com
VFC's Stock House
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
Clinton in debate says Sanders' healthcare promises 'cannot be kept'
11 Feb 2016 at 6:45pm
By John Whitesides MILWAUKEE (Reuters) - Democratic presidential candidate Hillary Clinton accused rival Bernie Sanders in a debate on Thursday of misleading Americans about the costs and viability of his healthcare plan, saying he was making promises "that cannot be kept." Clinton moved aggressively against Sanders early in their sixth presidential debate, saying Sanders' proposal for a single-payer, Medicare-for-all healthcare plan would mean dismantling Obamacare and triggering another intense political struggle. "You need to level with people about what they will have at the end of the process you are proposing," Clinton said. "That's a promise that cannot be kept." Sanders said he would not dismantle the healthcare plan known as Obamacare and was simply moving to provide what most industrialized countries have - universal healthcare.
Three dead in Venezuela after contracting Zika: Maduro
11 Feb 2016 at 6:17pm
Three people have died in Venezuela from complications linked to Zika, President Nicolas Maduro said -- the first fatalities reported in the country in connection with the mosquito-borne virus. Maduro said 68 patients with complications "have been in intensive care," adding that the country had the necessary drugs to treat them. Without providing any details, Maduro said that 5,221 suspected cases of Zika had been reported from November 5 until February 8.
Massive gas leak near Los Angeles plugged after 16 weeks
11 Feb 2016 at 5:15pm
LOS ANGELES (AP) ? A blowout at a natural gas well that leaked uncontrollably for 16 weeks and drove thousands of residents from their Los Angeles homes was plugged Thursday, a utility said.
Influential Texas panel recommends halt to use of bite-mark evidence
11 Feb 2016 at 4:00pm
An influential Texas scientific panel recommended on Thursday that bite-mark analysis not be admissible as evidence in courts, a decision experts said could lead judicial systems in other states to exclude it too. The Texas Forensic Science Commission panel recommended a moratorium on bite-mark evidence until there is science to support its admissibility. Bite-mark evidence has been used in U.S. courts for decades, most often to identify suspects in murders, sexual assaults and child abuse through marks on the flesh of victims.
Airports boost efforts to stop spread of Zika: UN agency
11 Feb 2016 at 2:42pm
Airports are stepping up efforts to reduce populations of mosquitoes that transmit the Zika virus in order to prevent its spread, the UN aviation agency said Thursday. "The management of the outbreak is currently focused on reducing the populations of the Aedes mosquito that transmit the virus at airports (vector control)," the International Civil Aviation Organization (ICAO) said in a statement. Vector control refers to the spraying of insecticides or other pest control measures.
Weight-loss surgery after age 35 linked to survival benefit
11 Feb 2016 at 2:16pm
By Andrew M. Seaman (Reuters Health) - Obese people who undergo a certain kind of weight-loss operation after age 35 may live longer than obese people of the same age who don't have the surgery, a study suggests. The findings, reported in JAMA Surgery, show that the so-called gastric bypass operation is associated with a mortality benefit along with its better-known "metabolic" benefits, said lead author Lance Davidson, of Brigham Young University in Provo, Utah. Past research has found weight loss surgeries are tied to reduced deaths from any cause, cancer and heart disease.
Brazil confirms third Zika-linked death
11 Feb 2016 at 2:02pm
Brasília (AFP) - Health authorities said Thursday they have identified a third death in Brazil linked to the Zika virus, but it is not clear if the disease was the sole cause. The latest case "was communicated to the World Health Organization [WHO] and we are studying it in more depth because we have just received the information," Health Minister Marcelo Castro said during a news conference. "It's not possible at this point to say that Zika was the sole cause of death," he said.
Textile workers at higher risk for rheumatoid arthritis
11 Feb 2016 at 1:30pm
By Lisa Rapaport (Reuters Health) - Breathing textile dust on the job is linked to an almost tripled risk of developing rheumatoid arthritis, an immune system disorder that causes debilitating swelling and pain in the joints, a Malaysian study suggests. While smoking is a known risk factor for this disease, the findings add to evidence suggesting that environmental factors could trigger rheumatoid arthritis in some people, the researchers note in the Annals of Rheumatic Diseases. The investigators suspect that textile dust might cause changes in the lung tissues, and those changes might trigger the immune response that leads to rheumatoid arthritis in individuals with genetic risk factors for the disease, said senior study author Dr. Camilla Bengtsson of the Karolinska Institute in Sweden.
Dems seek drug abuse funds as election-year issue sharpens
11 Feb 2016 at 1:03pm
WASHINGTON (AP) ? Congressional Democrats called Thursday for hundreds of millions in emergency spending to fight drug abuse but ran into Republican resistance as another health issue spiraled into an election-year showdown.
Convicted al Qaeda supporter loses U.S. medical malpractice trial
11 Feb 2016 at 12:04pm
The U.S. government owes nothing to a New York man, now in prison for aiding al Qaeda, who sought $7 million in damages for alleged medical malpractice that occurred after he was taken into custody, a federal judge ruled on Thursday. U.S. District Judge Gregory Woods in Manhattan said Wesam El-Hanafi, 40, presented no evidence at his malpractice trial showing that the prison system failed to diagnose and treat a blood clot in his leg in a timely fashion. "The plaintiff did not meet his legal burden of establishing any breach of duty of care or that such a breach was the proximate cause to his injury," Woods said in court.
Several states seek to block 2nd trimester abortion method
11 Feb 2016 at 11:50am
JACKSON, Miss. (AP) ? Abortion opponents in Mississippi, West Virginia and several other states are filing bills to ban an abortion procedure commonly used in the second trimester that opponents describe as dismembering a fetus.
Mom Pens Heartbreaking Letter to 4-Year-Old Daughter Who Died of Cancer
11 Feb 2016 at 11:22am
Kate Rhoades, 4, died on Jan. 12 from leukemia.
Study: Neanderthal DNA may influence modern depression risk
11 Feb 2016 at 11:14am
NEW YORK (AP) ? A new study says a person's risk of becoming depressed or hooked on smoking may be influenced by DNA inherited from Neanderthals.
Evidence grows for Zika role in brain damage
11 Feb 2016 at 11:03am
Evidence piled up Thursday implicating the Zika virus in a surge of brain damaged babies in Latin America, with two reports of the disease found in the neural tissue of affected infants. Scientists in Slovenia reported in the New England Journal of Medicine they had found traces of Zika virus in the brain of an aborted foetus with severe microcephaly, a condition that causes unusually small skulls and brains, leading to death or disability. The infant's mother, from Europe, had likely been infected with Zika in Brazil, which has borne the brunt of the virus outbreak and simultaneous microcephaly surge in Latin America and the Caribbean, they wrote.
Former Pakistan military leader Musharraf hospitalized with chest pain
11 Feb 2016 at 10:34am
Pakistan's former military ruler General Pervez Musharraf was taken to a hospital in the port city of Karachi on Thursday after complaining of chest pain and having difficulty breathing, a spokesman for his political party said. "He is not well," said Aasia Ishaque. "He felt serious discomfort in his chest and in breathing." Another leader of the party, Mohammad Amjad, said Musharraf was feeling better and would be released from the PNS Shifa Hospital shortly but that doctors would be closely monitoring him at home.